A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Intermediate to High Risk Myelofibrosis
Clinical trial NCT07443306 · RECRUITING
Trial details
- NCT number
- NCT07443306
- Sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2027-12-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.